EMV is up over 800% since its March lows this year. EMVision is developing a portable brain scanner for rapid, point of care, stroke diagnosis and monitoring which sounds like a good space to be in. I have had an alert set at RSI(14) < 65 for a while now to try and get back into it at better value, but I'm sill waiting :) From their about us: EMVision Medical...
Despite no real news Emvision has been having a bit of a run of late and looks to have cleared a small resistance area. Good chance it is running on people anticipating that the trial mention in early September might be about to begin. See announcement "03/09/2019 8:28 am AEST On Target For Trial To Commence Q4 Calendar 2019 ". Worth a watch. Blame or praise to...
EMV has seen continued absorption of shares following its recent rerate. With such a tight register and significant demand, coinciding with the resumption of the clinical trial, MRFF Stage 2 fund grant bids nearing completion (potential massive grant up for grabs that EMV has already successfully obtained stage 1) EMV is well poised to continue its upward trend....
EMV continues to demonstrate the lack of selling pressure post panic selling given macro global economic events. Hitting bottom of 40c some lucky punters picked a superb bottom and have since watched the price healthily appreciate through 2 continuation patterns. EMV's cash backing and potential for winning a undiluted funding through 2nd stage Medical Research...
hey traders, looking at EMV as a potential running flat. if you're looking for additional confirmation wait for sideways. however this looks probable.
The past several sessions have seen significant fear based selling as the C&H formation failed its handle. Unfortunate timing for the continuation pattern to be affected by the macro economic conditions. I would suspect that some of the supply that made it's way into the ask was from the 74c capital raise that took place late last year. The bottom may have been...
EMV has continued to impress with a tight capital structure and overwhelming demand. Capital Raise loose stock has been mostly absorbed in its pull back from $0.99 back down to $0.66. Once supply dwindled it was quite clear the bulls are fully in charge of the EMV trend. A C&H formation with a cup spread of 33.5c and what appears to be handle forming the last...
Emvision was out of the gates with an incredibly tight capital structure. Mkt cap $22.45M Ordinary fully paid shares 57,578,750 Options exercisable at $0.35 each 7,500,000 expiring on 31 Dec 2021 Performance Rights 6,000,000 $emv showed strength from day naught, and proceeded to demonstrate significant demand for the miniscule free float. A brief forced pull...